ArticleFrontiers in pharmacology2021

Kanglaite Combined With Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Therapy for Stage III/IV Non-Small Cell Lung Cancer: A PRISMA-Compliant Meta-Analysis.

Fanming Kong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.